Full-Time

Investment CRM Product Owner

Posted on 9/11/2025

Pantheon Ventures Careers

Pantheon Ventures Careers

201-500 employees

Global private markets investment manager

No salary listed

London, UK

In Person

Category
Product (2)
,
Required Skills
Salesforce
Requirements
  • Prior experience as a Product Owner / Product Manager within a private equity, private markets, or asset management environment
  • Direct hands-on experience with DealCloud (or equivalent CRM), ideally having led or played a major role in a system implementation at a comparable firm
  • Deep understanding of investment lifecycle processes, deal pipeline management, investor relations workflows, and fund operations
  • Strong knowledge of CRM system architecture, data governance, and integration with other platforms (e.g., portfolio monitoring, treasury, data warehouse)
  • Proven experience in vendor relationship management and contract/SLA oversight
  • Proven experience in successfully managing, influencing & partnering with a variety of stakeholders
  • Track record of leading cross-functional teams to deliver technology solutions in an agile, iterative manner
  • Demonstrated ability to manage escalations, mitigate risks, and deliver under pressure
  • Excellent communication skills, both written and verbal, with experience presenting to senior stakeholders
  • Strong project management and organisational skills, including attention to detail
  • Proficiency in MS Office (Excel, PowerPoint, Word); experience with Jira or similar agile delivery tools is advantageous
Responsibilities
  • Serve as overall Product Owner for DealCloud, responsible for backlog management, prioritisation, and delivery of enhancements
  • Define and maintain the product vision and roadmap, aligned with Pantheon’s business strategy and investment operations model
  • Oversee release planning, ensuring upgrades and new functionality are appropriately tested, validated, and deployed
  • Continuously monitor performance, usage, and value delivery from the system
  • Manage budget and commercials/contract with Dealcloud
  • Act as the primary liaison between business stakeholders, technology teams, and external providers
  • Partner with investment teams, investor relations, and operations to capture requirements and translate them into deliverable features
  • Provide senior-level communication on product performance, roadmap progress, and business impact
  • Manage expectations, resolve conflicts, and drive adoption across multiple stakeholder groups
  • Own the relationship with DealCloud and associated third-party providers
  • Lead vendor governance meetings, track SLAs, and escalate issues to ensure prompt resolution
  • Negotiate enhancements, support packages, and commercial terms where applicable
  • Oversee development of new CRM functionality (e.g., reporting, integrations, workflows)
  • Ensure changes comply with Pantheon governance standards, including data security and regulatory requirements
  • Coordinate cross-functional product teams, including business analysts, developers, and testers
  • Manage risk and contingency planning for incidents, outages, or product changes
  • Champion the CRM platform internally, driving user adoption and embedding best practices
  • Oversee training, communication, and business readiness activities associated with system enhancements
  • Collect and analyse user feedback to inform future development priorities
  • Serve as escalation point for system issues, ensuring timely resolution and minimal disruption to business operations
  • Define and monitor key product KPIs and success metrics
  • Contribute to Pantheon’s broader product operating model initiatives, working closely with other product owners across Treasury, AI services, and eFront
Pantheon Ventures Careers

Pantheon Ventures Careers

View

Pantheon manages investments in private markets for a broad base of institutional and private clients. It raises and allocates capital to private equity, infrastructure and other private market strategies, offering flagship funds, integrated programs, and customized solutions. The approach uses a global network with offices in multiple major cities to source deals, diversify risk, and tailor investments for each client. Pantheon also oversees listed investment vehicles Pantheon International Plc (PIP) and Pantheon Infrastructure Plc (PINT) on the London Stock Exchange. As of 2022, it reported about $88.9 billion in assets under management and advice, and employed over 460 people worldwide. The goal is to grow client portfolios by providing access to a wide range of private market opportunities across geographies and stages, backed by experienced teams and scalable investment structures.

Company Size

201-500

Company Stage

Private

Total Funding

$379.4M

Headquarters

London, United Kingdom

Founded

1982

Simplify Jobs

Simplify's Take

What believers are saying

  • AI Engineer hiring signals competitive advantage in portfolio analytics and deal sourcing capabilities.
  • eStruxture $1B co-investment positions Pantheon in high-growth Canadian data center infrastructure sector.
  • Career Pathways program and 470-person global team attract top talent in competitive private markets.

What critics are saying

  • AUM stagnant at $88.9B since 2022 despite favorable conditions; fundraising momentum unclear.
  • AMG majority ownership creates succession risk if parent divests or restructures asset management.
  • Infrastructure portfolio faces refinancing pressure as elevated rates compress returns on low-rate acquisitions.

What makes Pantheon Ventures Careers unique

  • Four-decade track record across private equity, infrastructure, and credit across Europe, US, and Asia.
  • Management equity ownership aligns incentives and enables autonomous operations within AMG structure.
  • Listed investment vehicles (PIP, PINT) on London Stock Exchange provide LP liquidity options.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Hybrid Work Options

Professional Development Budget

Company News

Benzinga
Mar 18th, 2026
QHP closes $1.1B continuation vehicle for Azurity Pharmaceuticals with HarbourVest

QHP Capital has closed a $1.1 billion continuation vehicle for Azurity Pharmaceuticals, providing liquidity to existing investors whilst securing long-term capital for growth. The transaction was led by HarbourVest Partners, with Pantheon Ventures and Audax Strategic Capital participating. The deal, announced on 13 February 2026, allowed limited partners in QHP's selling fund to either take returns or roll proceeds into the continuation vehicle. Strong participation came from existing limited partners, whilst QHP's subsequent fund remains a significant investor. The capital will support Azurity's organic growth, business development, licensing and potential mergers and acquisitions. Azurity is a specialty pharmaceutical company with a portfolio of over 50 medicines spanning 10 therapeutic areas, distributed across more than 50 countries.

Earth Press News
Feb 3rd, 2026
Eurazeo and Pantheon close €480M continuation fund for European private debt assets

Eurazeo, a French investment company managing €37.4 billion in assets, has closed a €480 million private debt continuation vehicle with Pantheon, a global private markets investor. The transaction involves establishing a continuation fund and purchasing a diversified portfolio of high-performing European senior credit assets from Eurazeo's legacy private debt platforms. Under the structure, Eurazeo will continue managing the assets whilst Pantheon provides additional capital, enabling Eurazeo to support medium-sized European businesses. The continuation fund offers liquidity to private investors whilst maintaining underlying asset stability. Nicolas Nedelec, partner of Eurazeo's private debt team, said the transaction demonstrates the strength of their platform and commitment to proactively managing fund lifecycles in investors' best interests.

Curium Pharma
Nov 20th, 2025
CapVest recapitalizes Curium to accelerate its growth strategy, marking the largest transaction in nuclear medicine globally - Curium Pharma

Curium and CapVest announce a $7B recapitalization - the largest transaction in nuclear medicine - to accelerate global innovation in diagnostic and therapeutic radiopharmaceuticals.

Bloomberg Law
Jul 16th, 2025
Pantheon Raises $2.2B for Credit Fund

Pantheon raised $2.2 billion for its latest opportunistic credit secondaries fund, nearly tripling its initial target of $750 million. Overall, Pantheon has gathered $8.3 billion in its third fundraising round for senior and opportunistic credit funds. In April, the firm secured $5.2 billion for its flagship credit secondaries fund focused on senior debt. Rakesh Jain, global head of private credit, highlighted this as a validation of market opportunity and their track record.

STT Info
Jun 30th, 2025
Vexve secures €521M for growth

DevCo Partners has secured €521 million in funding to support Vexve's next growth phase. The lead investor is Pantheon, with participation from North American and European family investment firms and institutional investors. About half of the funding comes from Vexve's current investors. The capital will aid Vexve's growth through organic means and acquisitions, driven by the accelerating energy transition.

INACTIVE